Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung cancer
Not Applicable
- Conditions
- on-small-cell lung cancer
- Registration Number
- JPRN-UMIN000022505
- Lead Sponsor
- Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Combined autoimmune disease or history of recurrent autoimmune disease 2. Interstitial lung disease 3. Severe medical comorbidities 4. Uncontrolled brain metastases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method